Mauna Kea Technologies SA announced that it has received 2.3 million in a round of funding on May 31, 2023. The transaction included participation from new investor Tasly Pharmaceutical Group Co., Ltd.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.415 EUR | +1.97% | +4.14% | -11.89% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
15.84 CNY | -0.44% | +2.46% | 3.27B | ||
0.415 EUR | +1.97% | +4.14% | 26.92M | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.89% | 26.92M | |
-17.11% | 18.51B | |
-42.09% | 2.85B | |
+23.15% | 1.95B | |
+3.08% | 1.72B | |
+28.27% | 1.26B | |
-11.16% | 1.02B | |
-17.21% | 950M | |
+0.07% | 777M | |
-23.17% | 643M |
- Stock Market
- Equities
- ALMKT Stock
- News Mauna Kea Technologies
- Mauna Kea Technologies SA announced that it has received €2.3 million in funding from Tasly Pharmaceutical Group Co., Ltd